David J Simmons, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 37 Palmer St, Calais, ME 04619 Phone: 207-454-8195 Fax: 207-454-3840 |
Dr. James Frederick Knudsen, PH.D., M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 70 Lafayette St, 421, Calais, ME 04619 Phone: 207-454-0053 |
Dr. Jose Gerardo Vergara, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 18 Palmer St, Suite 3, Calais, ME 04619 Phone: 207-454-8195 |
Dr. Elizabeth Eliacin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ln, Calais, ME 04619 Phone: 207-454-9300 Fax: 207-454-9238 |
Christopher Peter Corcoran, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 50 Union Street, Veterans Clinic, Calais, ME 04619 Phone: 207-904-3700 Fax: 207-904-3778 |
Peter Scott Wilkinson, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 37 Palmer St Ste 2, Calais, ME 04619 Phone: 207-454-8233 |
News Archive
A trace substance in caramelized sugar, when purified and given in appropriate doses, improves muscle regeneration in a mouse model of Duchenne muscular dystrophy. The findings are published today, Aug. 1, in the journal Skeletal Muscle.
Over 80% of all pharmaceutical products are in the solid dosage form. Particulate processes therefore abound in the pharmaceutical industry. These include crystallization; drying, granulation, and coating; tablet compaction; fine powder transport, mixing, and blending. These and other particulate processes are used for the large-scale manufacture of tablets and capsules as well as dry powder inhalants for public consumption.
The authors have explained that this could be a new approach to assessment of psychiatric diseases and conditions. They add that suicide risk is one of the most difficult conditions to be assessed and predicted.
American Medical Systems®, a leading provider of world-class devices and therapies for both male and female pelvic health, today announced that it has received clearance from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market and distribute its AMS 800 Artificial Urinary Sphincter (AUS) in Japan, effective September 7, 2009.
Today, Janssen-Cilag International NV announced that for the first time, European clinicians in six countries will meet to view and discuss broadcasts of the latest scientific research presented at the 2016 Genitourinary Cancers Symposium, co-sponsored by ASCO®.
› Verified 9 days ago